AGL expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 4.82709999971576E-07 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.846600E-04 |
Normal-vs-Stage2 |
1.777530E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
7.92210000000182E-05 |
Stage1-vs-Stage2 |
5.027900E-02 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
1.035200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.373800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.98590000502585E-08 |
Normal-vs-AfricanAmerican |
9.947600E-01 |
Normal-vs-Asian |
3.842600E-03 |
Caucasian-vs-AfricanAmerican |
7.785600E-04 |
Caucasian-vs-Asian |
9.326600E-01 |
AfricanAmerican-vs-Asian |
5.973800E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.73590000052526E-07 |
Normal-vs-Female |
1.371300E-04 |
Male-vs-Female |
3.210600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
9.81730000000347E-05 |
Normal-vs-Extreme_Weight |
1.70187999999349E-05 |
Normal-vs-Obese |
4.842900E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.525800E-01 |
Normal_Weight-vs-Obese |
4.662400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.056600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.642900E-03 |
Normal-vs-Age(41-60Yrs) |
7.768500E-04 |
Normal-vs-Age(61-80Yrs) |
2.36610000003967E-06 |
Normal-vs-Age(81-100Yrs) |
1.011630E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.203400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.126200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.674200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.197400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.199200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.400800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.445200E-01 |
Normal-vs-Grade 3 |
3.478600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.244000E-01 |
Grade 2-vs-Grade 4 |
4.445200E-01 |
Grade 3-vs-Grade 4 |
3.478600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.44790000000672E-06 |
Normal-vs-N1 |
3.779000E-04 |
N0-vs-N1 |
3.922400E-01 |
|
|